During the recent session, Windtree Therapeutics Inc (NASDAQ:WINT)’s traded shares were 1.46 million, with the beta value of the company hitting 0.54. The company’s market capitalization is $2.18M, and the average intraday trading volume over the past 10 days was 5.42 million shares, and the average trade volume was 2.05 million shares over the past three months.
Windtree Therapeutics Inc (WINT) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 3.00. WINT has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.92.
Windtree Therapeutics Inc (NASDAQ:WINT) trade information
Windtree Therapeutics Inc (WINT) registered a -1.99% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -1.99% in intraday trading to $0.20, hitting a weekly high. The stock’s 5-day price performance is -18.93%, and it has moved by -39.38% in 30 days. Based on these gigs, the overall price performance for the year is -97.84%. The short interest in Windtree Therapeutics Inc (NASDAQ:WINT) is 30861.0 shares and it means that shorts have 0.01 day(s) to cover.
Windtree Therapeutics Inc (WINT) estimates and forecasts
Statistics show that Windtree Therapeutics Inc has outperformed its competitors in share price, compared to the industry in which it operates. Windtree Therapeutics Inc (WINT) shares have gone down -94.52% during the last six months, with a year-to-date growth rate more than the industry average at 93.99% against 16.50.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 66.05%. While earnings are projected to return 94.00% in 2025.
WINT Dividends
Windtree Therapeutics Inc is due to release its next quarterly earnings in February. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Windtree Therapeutics Inc (NASDAQ:WINT)’s Major holders
Windtree Therapeutics Inc insiders own 0.27% of total outstanding shares while institutional holders control 2.06%, with the float percentage being 2.07%.
Also, the Mutual Funds coming in first place with the largest holdings of Windtree Therapeutics Inc (WINT) shares are Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund. Data provided on Nov 30, 2024 indicates that Fidelity Extended Market Index Fund owns about 3.32 shares. This amounts to just over 0.03 percent of the company’s overall shares, with a $653.0 market value. The same data shows that the other fund manager holds slightly less at 2.31, or about 0.02% of the stock, which is worth about $456.0.
